Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin.
Identifieur interne : 003615 ( PubMed/Checkpoint ); précédent : 003614; suivant : 003616Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin.
Auteurs : Susan O'Mahony [Royaume-Uni] ; Chandra K. Solanki ; Robert W. Barber ; Peter S. Mortimer ; Arnie D. Purushotham ; A Michael PetersSource :
- AJR. American journal of roentgenology [ 1546-3141 ] ; 2006.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Femelle, Humains, Immunoglobulines (administration et posologie), Injections sous-cutanées, Lymphoedème (imagerie diagnostique), Lymphoedème (étiologie), Scintigraphie, Sujet âgé, Technétium (administration et posologie), Tumeurs du sein (), Vaisseaux lymphatiques (imagerie diagnostique).
- MESH :
- administration et posologie : Immunoglobulines, Technétium.
- imagerie diagnostique : Lymphoedème, Vaisseaux lymphatiques.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Injections sous-cutanées, Scintigraphie, Sujet âgé, Tumeurs du sein.
English descriptors
- KwdEn :
- Adult, Aged, Breast Neoplasms (complications), Female, Humans, Immunoglobulins (administration & dosage), Injections, Subcutaneous, Lymphatic Vessels (diagnostic imaging), Lymphedema (diagnostic imaging), Lymphedema (etiology), Middle Aged, Radionuclide Imaging, Technetium (administration & dosage).
- MESH :
- chemical , administration & dosage : Immunoglobulins, Technetium.
- complications : Breast Neoplasms.
- diagnostic imaging : Lymphatic Vessels, Lymphedema.
- etiology : Lymphedema.
- Adult, Aged, Female, Humans, Injections, Subcutaneous, Middle Aged, Radionuclide Imaging.
Abstract
The disordered physiology that results from axillary lymph node clearance surgery for breast cancer and that leads to breast cancer-related lymphedema is poorly understood. Rerouting of lymph around the axilla or through new pathways in the axilla may protect women from breast cancer-related lymphedema. The aim of the study was to compare intradermal with subcutaneous injection of technetium-99m ((99m)Tc)-labeled human polyclonal IgG (HIG) with respect to lymphatic vessel imaging.
DOI: 10.2214/AJR.04.1341
PubMed: 16632730
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16632730Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin.</title><author><name sortKey="O Mahony, Susan" sort="O Mahony, Susan" uniqKey="O Mahony S" first="Susan" last="O'Mahony">Susan O'Mahony</name><affiliation wicri:level="1"><nlm:affiliation>Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge</wicri:regionArea><wicri:noRegion>Cambridge</wicri:noRegion></affiliation></author><author><name sortKey="Solanki, Chandra K" sort="Solanki, Chandra K" uniqKey="Solanki C" first="Chandra K" last="Solanki">Chandra K. Solanki</name></author><author><name sortKey="Barber, Robert W" sort="Barber, Robert W" uniqKey="Barber R" first="Robert W" last="Barber">Robert W. Barber</name></author><author><name sortKey="Mortimer, Peter S" sort="Mortimer, Peter S" uniqKey="Mortimer P" first="Peter S" last="Mortimer">Peter S. Mortimer</name></author><author><name sortKey="Purushotham, Arnie D" sort="Purushotham, Arnie D" uniqKey="Purushotham A" first="Arnie D" last="Purushotham">Arnie D. Purushotham</name></author><author><name sortKey="Peters, A Michael" sort="Peters, A Michael" uniqKey="Peters A" first="A Michael" last="Peters">A Michael Peters</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16632730</idno><idno type="pmid">16632730</idno><idno type="doi">10.2214/AJR.04.1341</idno><idno type="wicri:Area/PubMed/Corpus">003A19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A19</idno><idno type="wicri:Area/PubMed/Curation">003A19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003A19</idno><idno type="wicri:Area/PubMed/Checkpoint">003A19</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003A19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin.</title><author><name sortKey="O Mahony, Susan" sort="O Mahony, Susan" uniqKey="O Mahony S" first="Susan" last="O'Mahony">Susan O'Mahony</name><affiliation wicri:level="1"><nlm:affiliation>Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge</wicri:regionArea><wicri:noRegion>Cambridge</wicri:noRegion></affiliation></author><author><name sortKey="Solanki, Chandra K" sort="Solanki, Chandra K" uniqKey="Solanki C" first="Chandra K" last="Solanki">Chandra K. Solanki</name></author><author><name sortKey="Barber, Robert W" sort="Barber, Robert W" uniqKey="Barber R" first="Robert W" last="Barber">Robert W. Barber</name></author><author><name sortKey="Mortimer, Peter S" sort="Mortimer, Peter S" uniqKey="Mortimer P" first="Peter S" last="Mortimer">Peter S. Mortimer</name></author><author><name sortKey="Purushotham, Arnie D" sort="Purushotham, Arnie D" uniqKey="Purushotham A" first="Arnie D" last="Purushotham">Arnie D. Purushotham</name></author><author><name sortKey="Peters, A Michael" sort="Peters, A Michael" uniqKey="Peters A" first="A Michael" last="Peters">A Michael Peters</name></author></analytic><series><title level="j">AJR. American journal of roentgenology</title><idno type="eISSN">1546-3141</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Breast Neoplasms (complications)</term><term>Female</term><term>Humans</term><term>Immunoglobulins (administration & dosage)</term><term>Injections, Subcutaneous</term><term>Lymphatic Vessels (diagnostic imaging)</term><term>Lymphedema (diagnostic imaging)</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Radionuclide Imaging</term><term>Technetium (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Immunoglobulines (administration et posologie)</term><term>Injections sous-cutanées</term><term>Lymphoedème (imagerie diagnostique)</term><term>Lymphoedème (étiologie)</term><term>Scintigraphie</term><term>Sujet âgé</term><term>Technétium (administration et posologie)</term><term>Tumeurs du sein ()</term><term>Vaisseaux lymphatiques (imagerie diagnostique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Immunoglobulins</term><term>Technetium</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Immunoglobulines</term><term>Technétium</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphatic Vessels</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Lymphoedème</term><term>Vaisseaux lymphatiques</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Injections, Subcutaneous</term><term>Middle Aged</term><term>Radionuclide Imaging</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Injections sous-cutanées</term><term>Scintigraphie</term><term>Sujet âgé</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The disordered physiology that results from axillary lymph node clearance surgery for breast cancer and that leads to breast cancer-related lymphedema is poorly understood. Rerouting of lymph around the axilla or through new pathways in the axilla may protect women from breast cancer-related lymphedema. The aim of the study was to compare intradermal with subcutaneous injection of technetium-99m ((99m)Tc)-labeled human polyclonal IgG (HIG) with respect to lymphatic vessel imaging.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16632730</PMID><DateCreated><Year>2006</Year><Month>04</Month><Day>24</Day></DateCreated><DateCompleted><Year>2006</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1546-3141</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><Issue>5</Issue><PubDate><Year>2006</Year><Month>May</Month></PubDate></JournalIssue><Title>AJR. American journal of roentgenology</Title><ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation></Journal><ArticleTitle>Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin.</ArticleTitle><Pagination><MedlinePgn>1349-55</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The disordered physiology that results from axillary lymph node clearance surgery for breast cancer and that leads to breast cancer-related lymphedema is poorly understood. Rerouting of lymph around the axilla or through new pathways in the axilla may protect women from breast cancer-related lymphedema. The aim of the study was to compare intradermal with subcutaneous injection of technetium-99m ((99m)Tc)-labeled human polyclonal IgG (HIG) with respect to lymphatic vessel imaging.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Six women with breast cancer-related lymphedema underwent unilateral upper limb lymphoscintigraphy, using a web space injection of (99m)Tc-labeled HIG, after intradermal and subcutaneous injections on separate occasions. Multiple sequential images were obtained of the affected upper limb and torso over 3 hr on each occasion. Accumulation of activity in blood was quantified from venous blood samples taken from the opposite arm.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Imaging after intradermal injection clearly showed discrete lymphatic vessels in five of six patients, in contrast to imaging after subcutaneous injection, which did not show any discrete vessels in any patient. Intradermal injection resulted in more rapid visualization of cutaneous lymph rerouting than subcutaneous injection in six of six patients. Recovery of injected (99m)Tc-labeled HIG in venous blood was greater after intradermal injection in six of six patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients with breast cancer-related lymphedema, lymphatic vessels are more clearly depicted after intradermal than subcutaneous injection as a result of direct access of radiotracer to dermal lymphatics. This finding has implications for imaging lymphatic vessel regeneration and lymph rerouting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Mahony</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solanki</LastName><ForeName>Chandra K</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Mortimer</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Purushotham</LastName><ForeName>Arnie D</ForeName><Initials>AD</Initials></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>A Michael</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJR Am J Roentgenol</MedlineTA><NlmUniqueID>7708173</NlmUniqueID><ISSNLinking>0361-803X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C065376">technetium Tc 99m immunoglobulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>7440-26-8</RegistryNumber><NameOfSubstance UI="D013667">Technetium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007136" MajorTopicYN="Y">Immunoglobulins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007279" MajorTopicYN="N">Injections, Subcutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013667" MajorTopicYN="Y">Technetium</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>4</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>7</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>4</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16632730</ArticleId><ArticleId IdType="pii">186/5/1349</ArticleId><ArticleId IdType="doi">10.2214/AJR.04.1341</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><noCountry><name sortKey="Barber, Robert W" sort="Barber, Robert W" uniqKey="Barber R" first="Robert W" last="Barber">Robert W. Barber</name><name sortKey="Mortimer, Peter S" sort="Mortimer, Peter S" uniqKey="Mortimer P" first="Peter S" last="Mortimer">Peter S. Mortimer</name><name sortKey="Peters, A Michael" sort="Peters, A Michael" uniqKey="Peters A" first="A Michael" last="Peters">A Michael Peters</name><name sortKey="Purushotham, Arnie D" sort="Purushotham, Arnie D" uniqKey="Purushotham A" first="Arnie D" last="Purushotham">Arnie D. Purushotham</name><name sortKey="Solanki, Chandra K" sort="Solanki, Chandra K" uniqKey="Solanki C" first="Chandra K" last="Solanki">Chandra K. Solanki</name></noCountry><country name="Royaume-Uni"><noRegion><name sortKey="O Mahony, Susan" sort="O Mahony, Susan" uniqKey="O Mahony S" first="Susan" last="O'Mahony">Susan O'Mahony</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003615 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003615 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16632730
|texte= Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16632730" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |